Investment bank Kempen is sole global coordinator for the initial public offering (IPO) after Cardio3 tried unsuccessfully to float in 2011.
Grifols-backed Cardio3 Biosciences that last month raised €19m in its series C round said it is planning a flotation in Brussels, Belgium, and Paris, France.
Investment bank Kempen is sole global coordinator for the initial public offering (IPO) after Cardio3 tried unsuccessfully to float in 2011.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
